◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

PHYSICIANS FORMULA HOLDINGS, INC.

CIK: 1269871 SIC: 2844
$94.51M
Revenue
$2.25M
Net Income
49.52%
Gross Margin
6.66%
Op. Margin
$26.42M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 1 of 1 annual reports available (2011 - 2011)
Breakdown TTM
(Sep 30, 2012)
FY 2011
(Dec 31, 2011)
+ Total Revenue $94.51M $80.94M
Revenue Growth % 16.8% nan%
Cost of Revenue $47.70M $42.71M
+ Gross Profit $46.80M $38.22M
Gross Margin % 49.5% 47.2%
+ Operating Income $6.29M $1.08M
Operating Margin % 6.7% 1.3%
Interest Expense $881.00K $1.24M
Income Before Tax $4.29M $-2.42M
Income Tax Expense $2.04M $-1.22M
+ Net Income $2.25M $-1.20M
Net Margin % 2.4% -1.5%
Basic EPS 0.16 -0.09
Diluted EPS 0.13 -0.09
Basic Shares Outstanding 13.7M 13.6M
Diluted Shares Outstanding 13.7M 13.6M
Breakdown FY 2011
(Dec 31, 2011)
Cash & Cash Equivalents $3.00K
Accounts Receivable $25.76M
Inventory $25.22M
Other Current Assets $1.94M
Total Current Assets $62.04M
Property Plant & Equipment $2.60M
Intangible Assets $30.49M
Other Non-current Assets $5.36M
Total Assets $100.48M
Accounts Payable $10.45M
Accrued Liabilities $3.74M
Total Current Liabilities $38.27M
Long-term Debt $2.92M
Other Non-current Liabilities $272.00K
Total Liabilities $49.62M
Common Stock $136.00K
Retained Earnings $-12.09M
Total Stockholders Equity $50.86M
Total Liabilities & Equity $100.48M
Breakdown TTM
(Sep 30, 2012)
FY 2011
(Dec 31, 2011)
Net Income $4.68M $-1.20M
Depreciation & Amortization $8.30M $4.96M
Stock-based Compensation $825.00K $755.00K
Deferred Income Tax $449.00K $-1.61M
Change in Receivables $-7.98M $1.86M
Change in Inventory $-2.84M $1.86M
Change in Payables $-1.65M $1.62M
Operating Cash Flow $27.28M $5.22M
Capital Expenditure $855.00K $1.12M
Investing Cash Flow $-5.75M $-3.84M
Financing Cash Flow $-15.31M $-1.49M
Net Change in Cash $6.22M $-107.00K
SEC Filing Format - Data shown as it appears in the Q3 2012 (10-Q) filing Period ended: Sep 30, 2012
Condensed Consolidated Statements of Operations
Description Sep 30, 2012 Sep 30, 2012
Current Prior Year Current YTD Prior Year YTD
Total Revenue $19.11M $15.87M $71.45M $57.88M
Cost of Revenue $9.50M $7.99M $34.62M $29.63M
Gross Profit $9.61M $7.88M $36.83M $28.25M
Selling General & Admin $10.27M $8.30M $30.52M $27.15M
Operating Income $-665.00K $-415.00K $6.30M $1.09M
Interest Expense - - $287.00K $978.00K
Income Before Tax $-771.00K $-1.06M $5.94M $-767.00K
Income Tax Expense $571.00K $-527.00K $2.90M $-353.00K
Net Income $-1.34M $-537.00K $3.04M $-414.00K
Basic EPS -0.10 -0.04 0.22 -0.03
Diluted EPS -0.10 -0.04 0.20 -0.03
Basic Shares Outstanding $13.71M $13.61M $13.70M $13.60M
Diluted Shares Outstanding $13.71M $13.61M $14.98M $13.60M
Condensed Consolidated Balance Sheets
Description Sep 30, 2012 Dec 31, 2011
Cash & Cash Equivalents $5.37M $3.00K
Accounts Receivable $18.51M $25.76M
Inventory $25.02M $25.22M
Other Current Assets $1.72M $1.94M
Total Current Assets $59.09M $62.04M
Property Plant & Equipment $2.17M $2.60M
Intangible Assets $29.16M $30.49M
Other Non-current Assets $4.89M $5.36M
Total Assets $95.30M $100.48M
Accounts Payable $10.48M $10.45M
Accrued Liabilities $2.04M $3.74M
Total Current Liabilities $30.24M $38.27M
Long-term Debt $2.17M $2.92M
Other Non-current Liabilities $310.00K $272.00K
Total Liabilities $40.87M $49.62M
Common Stock $137.00K $136.00K
Retained Earnings $-9.05M $-12.09M
Total Stockholders Equity $54.44M $50.86M
Total Liabilities & Equity $95.30M $100.48M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2012 Sep 30, 2012
Current Prior Year Current YTD Prior Year YTD
Net Income $-1.34M $-537.00K $3.04M $-414.00K
Depreciation & Amortization - - $3.49M $3.71M
Stock-based Compensation - - $304.00K $550.00K
Deferred Income Tax - - $505.00K -
Change in Receivables - - $-7.34M $-8.60M
Change in Inventory - - $-229.00K $977.00K
Change in Payables - - $456.00K $-2.12M
Operating Cash Flow - - $12.54M $4.73M
Capital Expenditure - - $260.00K $860.00K
Investing Cash Flow - - $-1.93M $-3.27M
Debt Repayment - - $750.00K -
Financing Cash Flow - - $-5.25M $-1.19M
Net Change in Cash - - $5.36M $272.00K

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...